CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
DNA Chip Research, Inc. Company Snapshot
DNA Chip Research, Inc. operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares DNA Chip Research with three other companies in this sector in Japan: BrightPath Biotherapeutics Co Ltd (2017 sales of 529.61 million Japanese Yen [US$4.69 million] of which 100% was Commerical Physical Research), Nanocarrier Company Limited (218.69 million Japanese Yen [US$1.94 million] of which 100% was Research and Development), and Onco Therapy Science, Inc (286.67 million Japanese Yen [US$2.54 million] of which 100% was Research & Development In Medical).

Sales Analysis. DNA Chip Research reported sales of ¥324.65 million (US$2.87 million) for the fiscal year ending March of 2017. This represents an increase of 14.2% versus 2016, when the company's sales were ¥284.16 million. Despite this increase, sales are still below the level achieved in 2015, when DNA Chip Research reported sales of ¥357.32 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
DNA Chip Research, Inc.
  Stock Performance Chart for DNA Chip Research, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (10/20/2017): 1,190.00
(Figures in Japanese Yen)
1 Week -7.8%   13 Weeks -14.1%  
4 Weeks -3.3%   52 Weeks 81.4%  
 
DNA Chip Research, Inc. Key Data:
  Ticker: 2397 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 324,646,000
(Year Ending Jan 2018).
Employees: 27
  Currency: Japanese Yen Market Cap: 5,042,751,140
  Fiscal Yr Ends: March Shares Outstanding: 4,237,606
  Share Type: Common Closely Held Shares: 1,357,700
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.